Project Grant R01AR085626
Award Date
7/25/25
Completion Date
5/31/30
Dollars Obligated
$508K
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $605,253 to The Trustees of the University of Pennsylvania to investigate the mechanical crosstalk between the intervertebral disc and adjacent facet joints during spinal degeneration and repair. The research aims to characterize the progression of facet osteoarthritis following disc...
This Project Grant award of $624,004.07 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), supports research at Thomas Jefferson University investigating the role of hypoxia-inducible factor 1 (HIF-1) in maintaining intervertebral disc function. The key objectives of this 1-year award, with a project period from September 2024 to September 2025, are to: 1) determine the...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), aims to develop injectable, cell-adhesive, and growth factor-presenting alginate hydrogels to enhance the therapeutic potential of mesenchymal stem cells (MSCs) for intervertebral disc (IVD) repair. The $752,620 award, spanning September 2024 to August 2026, will fund in vitro studies of MSCs...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), aims to locally deliver a small molecule Hedgehog (HH) signaling agonist to improve tendon-to-bone integration following anterior cruciate ligament (ACL) reconstruction. The $1,060,925 award will fund in vitro release studies to test the duration and bioactivity of the agonist released from...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA 93.846 Arthritis, Musculoskeletal and Skin Diseases Research will support research to investigate the role of DNA methylation in intervertebral disc degeneration and chronic low back pain. The $658,385 award will fund a 5-year project to: 1) Identify the DNA methylation and gene expression landscape in human intervertebral disc degeneration and discogenic low back pain, 2)...
The federal Project Grant award R01AR085553, provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), supports research aimed at understanding the roles of monocytes in the progression of acute and chronic back pain associated with intervertebral disc herniation. The total funding amount is $568,462.00, awarded from July 1, 2025 through March 31, 2030. The research,...
Cornell University received a $100,000 Project Grant from the National Science Foundation to develop a tissue-engineered intervertebral disc with a biodegradable cage. The goal of the one-year project under the NSF Technology, Innovation, and Partnership's CFDA 47.084 program is to advance the commercial potential of a tissue-engineered solution to treat intervertebral disc degeneration. Intervertebral disc degeneration is a leading cause of disability in the United States, costing $100B...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), is providing $1,013,625 to the University of Pittsburgh to investigate the use of a porcine small intestine submucosa (SIS) scaffold for temporomandibular joint (TMJ) disc regeneration. The goal is to develop a safe and effective treatment for TMJ disc replacement, addressing the lack of FDA-approved options that leads to joint...
This $360,580 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), supports research to develop an engineered extracellular matrix (EECM) that can promote regenerative healing in tendons. The University of Oregon will fabricate anisotropic PEG hydrogel-based EECM scaffolds and evaluate their ability to guide the alignment and matrix deposition of human...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under CFDA Program 93.846 Arthritis, Musculoskeletal and Skin Diseases Research, provides $600,475 to the University of California, Davis to develop a collagen-based scaffold modified with specific integrin ligands and placental mesenchymal stem cell-derived extracellular vesicles. This innovative fetal tissue engineering approach aims to synergistically recruit and guide endogenous...